Medicare AdvantageCoverageMedium impact
Cardioverter Defibrillators/Cardiac Resynchronization Therapy - Medicare Advantage (Revised)
Humana·Cardiology, Cardiothoracic Surgery, Critical Care·Medicare Advantage
We identified it
Jul 30, 2026
Summary
This is a revised Medicare Advantage policy on Implantable Cardioverter Defibrillators (ICDs) and Cardiac Resynchronization Therapy (CRT) devices. The policy appears to be a clarification or update to existing coverage criteria for these life-saving cardiac devices, but the provided content is incomplete (cut off mid-sentence) and lacks specific billing code guidance, coverage determinations, prior authorization requirements, or effective date information.
Action Required
CRITICAL: Billing team must obtain the COMPLETE policy document immediately. The provided summary is truncated and does not contain sufficient detail for implementation. Contact Humana Medicare Advantage directly using the source URL (https://dctm.humana.com/Mentor/Web/v.aspx?objectID=090009298a58fcbe) or your Humana representative to request: (1) The full policy text, (2) Specific CPT and HCPCS codes affected, (3) Prior authorization requirements and procedures, (4) Effective date of this revision, (5) Any superseded policies this replaces. Do not update billing workflows until complete policy is reviewed. Flag all ICD and CRT device claims for manual review pending full policy clarification.